the everyone. a first and time Stuart, you on company. Thank you, to today We conference appreciate us good public morning, join as taking our call
and a benefit address tissue reconstruction. new For a to are technology in of stage soft commercial new reinforcement designing, marketing we you tissue of Bio, medical developing those focused to needs the who may category TELA be unmet materials company of on
and respectively, unique layers fibers reconstructive PRS material in construction. products targeting a markets of Our with hernia integrate biologic the and OviTex OviTex plastic polymer repair and high embroidered quality surgery
implanted to and to over costs improve in designed care been X,XXX materials based reduce are relative overall and to patients outcomes have products date. Our other biologic of clinical
continue monitor impact Before highlights, on business. employees and operational of reviewing customers, patients, the COVID-XX closely our to we our
are finish our commentary drivers business more. adapting how additional the would review continue growth and that in our strategies XXXX shortly we on we we strong to learn in and our as XXXX. to But will We for fundamental provide like first
XXXX adoption We delivered driven OviTex $X.X Bio, the total PRS expansion by over the XXXX. our momentum characterized and for continued and product business, organization. representing by prior in and $XX.X of XXXX, growth from XX% for million exciting an million of year our of period in line was revenue OviTex total strong quarter fourth revenue in the commercial XXX% year full-year up our TELA for and XXXX, growth
sales multiple saw hospital provide and GPO of and X,XXX improved national the XXXX, U.S., hospital accounts. from XXXX hospital had We awarded accounts to approximately territories third being At access X,XXX quarter accounts at contracts hospital XX is we increase with access with up over group through including contracts estimate purchasing organizations, current to approximately GPO large our year-end to XX us members. active XXX end which We end the XXXX, of with the at territories an of XXXX. XX in exited the from a
have Throughout members. focused health implementation XXXX, contracts GPO highly working we process executing will with their system GPO and begun be these in against each on hand-in-hand the
and procedure -- plan our surgical volume. strategy, and closely on is GPO creating areas territories expansion territory aligned Our based access with new potential hospital procedural high
strategy impact planned on and to conservative due growth are we is the to Chief sales territories of have we We force ensure confirm Murphy to Through as having conform continue business. to appointment with than Officer, to productivity. optimize -- driving Commercial our this COVID-XX recent approach. the evaluate commercial have plan and Pete also hiring optimized our shifted legacy our more to our expansion, initially we Related a
strong outcomes. X% data in hernia rate deliver repair hernia continue XX first post-market from named for showing multicenter the products prospective our OviTex failure our We patients at abdominal or study XX a Clinically, publish recurrence to reconstruction months and BRAVO, wall studied.
the cohort patient XX expanded days. XX at and As the cohorts conducted at to data XX we BRAVO continue months recently and months analysis first mature, on
upcoming We have continue expand in abstracts medical contributing conferences presentations. to XXXX, Symposium. growth. hernia presentation submitted usage were for these accepted revenue clinical robotic Minimally OviTex Invasive for Surgery poster our portfolio, product our data Throughout characterizing to to Two repair, the also we at
of additional sized reconstructions. devices sizes laparoscopic For wall year our and hernia in we line repair. products, ventral LPR added December our OviTex designed we OviTex three use to beginning complex for product for the at large and abdominal hernia launch the In hernias XXXX, robotic
we XXXX, range solution being of of continue hernia time introduce the implanted further. capable to robust our full a additional we'll and Entering products across have enhance surgery over hernia to portfolio
For plastic mid in following the products and a launch our reconstruction controlled XXXX devices. surgery, clearance we of PRS OviTex initiated XXX(k) of
to to enter sure The being provided Based commercializing plan in us PRS clinical on to XXXX. a in gradually OviTex employed the valuable is and performance surgery the expanding feedback of have continue procedures. implantations intend date, market, plastic of to manner, controlled our products on throughout surgeons network we reconstructive techniques with surgeon the these of while controlled surgical our and methodically this carefully feedback gather and across launch variety
intend to new expansion hernia develop portfolio to products, hernia -- product OviTex surgeon of our OviTex enhance we generations incorporate portfolio. feedback PRS Similar to to of of our products
impact of Now business. our on the COVID-XX to turning
Many a notices Chinese and are repair improve commercial have footprint later non-essential personnel, measures. systems they work limit access spread deferred to While sales and be and the are supply of surgeries the markets, our the largely to mitigate to European date. sent including postponed able to as hernia representatives, many out virus from hospital insulated chain also containment and to
volume commercial to are shifted conservative plan. QX we more in a While in we XXXX, seeing procedural a reduction hiring have
unprecedented diligently and this ourselves We position working our strength time. are protect of position a throughout to business in
our partner with chain tactics, and solutions supply to educate hospital marketing sales innovative product deploying surgeons us and implementing allow customers implementation to that are discussions. portfolio virtual our continue contract We on effectively
to We our in-house of the reach a impact are education by maximize potential third-party efforts. organization augmenting of the our commercial
additional We and are team our high to our service to for ensure our training as also enhance impact further continues resource organization throughout initiatives customers. a commercial our serve level implementing of
continue impact to hospital our surgeons, with We extent work this team customers business. sales which understand the may and and dynamic better it to to our
today's situation, our market provide more Due provide conditions. to May hope nature QX QX stable the on call, guidance to will fluid of on full-year and assuming revenue guidance XXXX during the in earnings our XXXX call we
review to and full-year summary. the our I over would call financial quarter turn Nora like fourth to to